Pipeline
Our Commercial and Development Pipeline is Focused on Serving
the Unmet Medical Needs of Patients with Rare Endocrine Diseases
Pipeline Growth Opportunities
Working towards building a pipeline beyond diagnostics – our goals include:
Exploring Macimorelin
as a Potential
Therapeutic
We are evaluating the potential of macimorelin as a therapeutic agent in various indications
Seeking to Activate Opportunities for Other Currently Owned Assets
Strategic review of current assets to identify potential program to activate and advance
Evaluating Potential
In-Licensing
Opportunities
Engaging with our extensive network with universities in Europe and U.S. to identify other potential opportunities that build on our extensive knowledge and experience